Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

New Gel for Liver Cell Culture on Microchips

By Linköping University | February 14, 2019

Scientists at Linköping University, Sweden, have developed a new method to produce hydrated materials, hydrogels, that have properties similar to the natural environment of cells in the body. The material can be adapted to the various requirements of difficult-to-culture cell types, and to produce organ-like structures on a microchip. Credit: Karin Söderlund Leifler/Linköping University

Scientists at Linköping University have developed a new method to produce hydrated materials, hydrogels, that have properties similar to the natural environment of cells in the body. They describe in an article in Biofabrication how to adapt the material to the various requirements of difficult-to-culture cell types, and to produce organ-like structures on a microchip.

Cells cultured in the lab have many applications, one of which is to test whether various new substances harm the cells. A rapidly growing technique known as organ-on-a-chip involves culturing cells from human organs on small chips with a supply of oxygen and nutrients. Scientists are attempting to develop models of increasing complexity that simulate the way in which tissue or complete organs function in the body. Such models can be used in many areas of medical research, such as testing potential medicines, and may, in the long term, replace some animal experiments.

It is, however, not easy to culture human cells. They often have very specific requirements, and die easily. In the body, the cells are surrounded by a supporting structure known as a matrix. This is a type of hydrated gel, and consists mainly of proteins and carbohydrates. The environment of the cells differs from one tissue type to another, and has a major effect on cell function. Researchers at Linköping University are developing soft materials that imitate more closely the natural surroundings of cells in the body, for use in cell culture.

“Our new material allows the properties to be adapted across a wide range. New functionalities, such as small protein fragments that the cells need, can be incorporated, such that even picky cells can replicate and function”, says Daniel Aili, who, together with Carl-Fredrik Mandenius, has led the study. Both work in the Department of Physics, Chemistry and Biology at Linköping University.

The material consists of two components that are mixed in water, together with living cells. A chemical reaction takes place that causes the components to form a hydrated gel, a hydrogel, similar to the naturally occurring matrix. This chemical reaction takes place spontaneously and does not affect the cells. The scientists have carried out extensive tests of the hydrogel properties and compared it with other commonly used materials.

“We can adapt the mechanical properties of the hydrogel within a wide range. We can also control the speed of formation of the gel: it’s important that it doesn’t occur too rapidly or too slowly,” says Daniel Aili.

The liver is important in the testing of new pharmaceutical substances, since the liver processes many of the drugs that we take. For this reason, the researchers have tested using the hydrogel to create a human liver-on-a-chip, using liver cells derived in culture from stem cells. The research team were able to adapt the material such that even these rather demanding cells could proliferate and function. In its basic configuration, the hydrogel does not contain proteins, but the researchers included in the material a synthetic fragment of an important protein found in the tissue that surrounds the human liver. When they added this protein-mimicking component to the hydrogel, the liver cells on the chip started to produce albumin, just as the liver does in the body.

“The principal significance of our material may be in the development of useful models of the liver, which can be used to simplify the early stages of drug development. Our hydrogel is extremely interesting for anyone who wants to have control of the contents of the material in which the cells are cultured. And it’s easy to adapt to different types of cell and tissue,” says Daniel Aili.


Filed Under: Drug Discovery

 

Related Articles Read More >

Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE